Kodiak Sciences (NASDAQ:KOD) reported that its Phase III DAYBREAK study met primary endpoints for two investigational ...
Gilead Sciences (GILD) stock rose 35% in 12 months. HIV drug Biktarvy generated $3.8B quarterly. Analysts project $158 target with raised guidance to $30.4B.
It has been a remarkable journey for Kodiak Sciences Inc. , whose share price has nearly tripled in just one month, climbing ...
"I like biology, but I'm not good at chemistry."This is a common concern among high school students considering a path in the life sciences.DNA, cells, microorganisms, plants, animals. High school ...
I like biology, but I'm not good at math.I think this is a very common concern for high school students considering the life ...
ODC Life Sciences Brings Together Leaders to Explore Brazil’s Role in Global Clinical Development / ANVISA, artificial ...
ZYUS Life Sciences Corporation (the "Company" and or "ZYUS") (TSXV: ZYUS), a clinical-stage life sciences company focused on ...
In Our DNA will showcase the research, education and people from the School of Health & Medical Sciences shaping the future ...
The use of social media influencers to expand awareness and promote prescription drugs, medical devices and health-related products has grown ...
Indo Borax & Chemicals Limited (BSE:524342) executed a Share Purchase Agreement to acquire 64.26% stake in Kronox Lab Sciences Limited (NSEI:KRONOX) from Ketan Vinodchandra Ramani, Pritesh ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results